Cargando…

Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes

Detalles Bibliográficos
Autores principales: Friedman, Eli A., Banerji, Mary Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114366/
https://www.ncbi.nlm.nih.gov/pubmed/21617113
http://dx.doi.org/10.2337/dc11-0576
_version_ 1782206054496468992
author Friedman, Eli A.
Banerji, Mary Ann
author_facet Friedman, Eli A.
Banerji, Mary Ann
author_sort Friedman, Eli A.
collection PubMed
description
format Online
Article
Text
id pubmed-3114366
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31143662012-06-01 Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes Friedman, Eli A. Banerji, Mary Ann Diabetes Care Editorials American Diabetes Association 2011-06 2011-05-20 /pmc/articles/PMC3114366/ /pubmed/21617113 http://dx.doi.org/10.2337/dc11-0576 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Editorials
Friedman, Eli A.
Banerji, Mary Ann
Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title_full Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title_fullStr Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title_full_unstemmed Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title_short Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes
title_sort chronobiology impacts response to antihypertensive drug regimen in type 2 diabetes
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114366/
https://www.ncbi.nlm.nih.gov/pubmed/21617113
http://dx.doi.org/10.2337/dc11-0576
work_keys_str_mv AT friedmanelia chronobiologyimpactsresponsetoantihypertensivedrugregimenintype2diabetes
AT banerjimaryann chronobiologyimpactsresponsetoantihypertensivedrugregimenintype2diabetes